New York City, NY (PRWEB) August 19, 2013
Fertility Nutraceuticals, LLC, a leading supplier of men’s and women’s fertility supplement products, announced the release of their newest fertility product for women, OVOENERGEN™. OVOENERGEN™ is a mega-dose nutritional supplement of pharmaceutical-grade coenzyme Q10 (CoQ10), developed in consultation with Dr. Robert Casper, Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, Canada, the leading fertility expert and researcher of CoQ10 in women. OVOENERGEN™ CoQ10 is specifically designed to enhance female fertility by improving overall egg quality.
The CoQ10 in OVOENERGEN™ is a vitamin-like substance that acts as an antioxidant found throughout the body. CoQ10 has been used for a long time in male fertility context, but its use in women trying to conceive has drawn attention only recently. Dr. Casper’s preliminary study using 1000 mg daily of CoQ10 supplementation has shown its promising ability to support healthy egg development in the ovary. OVOENERGEN™ CoQ10 has been developed to replicate this experience.
Every package of OVOENERGEN™ contains four sheets of 21 soft gels, to be taken three times a day, seven days a week (84 soft gels total). OVOENERGEN™ is competitively priced at $195 per month and delivers more than three times the amount of CoQ10 per serving as in most other CoQ10 supplements. OVOENERGEN™ is available now and can be purchased via the Fertility Nutraceuticals, LLC’s http://www.fertinatal.com/shop/.
In addition to OVOENERGEN™, Fertility Nutraceuticals, LLC has also released ANDROENERGEN™ for men. ANDROENERGEN™ is a fertility supplement designed to support healthy sperm development.
About Fertility Nutraceuticals, LLC:
Fertility Nutraceuticals, LLC is a young company exclusively dedicated to highest-quality nutritional supplements for fertility. FERTINATAL® DHEA supplement is the company’s flagship product, with OVOENERGEN™ and ANDROENERGEN™ offering additional options. For more information, visit http://www.fertinatal.com.
Read the full story at http://www.prweb.com/releases/2013/8/prweb10514486.htm.
Copyright©2012 Vocus, Inc.
All rights reserved